Breast cancer (invasive) · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	surveillance
Linked regimen	`None`

ID	`IND-SEVERE-OBESITY-CANCER-PREVENTION-OBSERVATION`
Type	Indication
Status	reviewed 2026-05-20 \| pending_clinical_signoff
Diseases	`DIS-BREAST`
Sources	`SRC-WCRF-AICR-CUP-2018`

Notes

STUB pending two-Co-Lead signoff per CHARTER §6.1 dev-mode. v0.3 wave-N niche pathway alternative track (severe obesity BMI ≥40). Sibling — IND-SEVERE-OBESITY-CANCER-PREVENTION-INTENSIFIED. §15.2 C4 ≥2-tracks invariant.

Used By

Indication

IND-SEVERE-OBESITY-CANCER-PREVENTION-INTENSIFIED - IND-SEVERE-OBESITY-CANCER-PREVENTION-INTENSIFIED

Red flag

RF-CHRONIC-SEVERE-OBESITY-BMI40-PREVENTION - Severe obesity — BMI ≥40 kg/m² (WHO class III obesity), distinct from the broader RF-LIFE...